SARS_CoV_2 mutation literature information.


  Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds.
 PMID: 34337269       2021       ACS omega
Abstract: The concordance and rigidity ratios of multiple mutation strains such as B.1.617.2 against the wild-type one at the receptor-binding domain (RBD) and receptor-binding motif (RBM) regions provide a good indication of the transmissibility and neutralization escape ability except for binding affinity of mutation sites such as N501Y.
Introduction: Although the high binding affinity of the mutation site such as N501Y in B.1.1.7 (alpha) expanded from UK and in B.1.351 (beta) circulated from South Africa, which was measured by the quantitative deep mutational scanning, can rationalize the increased infections, identifying the fundamental cause of vaccine nullification is difficult in general, and is a source of significant concern.
Introduction: B.1.1.7 is prevalent all over the world, but the N501Y frequency of phylogeny is about 60-70% ().


  Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
 PMID: 34341794       2021       bioRxiv
Introduction: As shown in Figure 2B,C, Alpha and Beta variants include N501Y mutation, while Beta variant involves two additional mutations, K417N and E484K.
Introduction: However, only the N501Y mutation was examined in their study, although other potentially important mutations have emerged.
Introduction: Such contacts are decreased or even lost in the case of RBDWT or RBDEpsilon lacking the N501Y mutation (Figure 2A,D).


  Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.
 PMID: 34346317       2021       Computers in biology and medicine
Abstract: Further, the molecular dynamics simulation (MDS) approach reveals the structural transition of mutants (N501Y and D614G) S-protein.
Abstract: Using the extensive bioinformatics pipeline, we screened the destabilizing (L8V, L8W, L18F, Y145H, M153T, F157S, G476S, L611F, A879S, C1247F, and C1254F) and stabilizing (H49Y, S50L, N501Y, D614G,


  Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
 PMID: 34346753       2021       Microbiology spectrum
Abstract: For the B.1.1.7 variant, we demonstrated the critical importance of mutations D614G and N501Y on the structure and binding, respectively, of the Spike protein.
Introduction: We are able to demonstrate dynamic changes in the B.1.1.7 spike protein that can be traced to two key mutations, resulting in a more accessible Result: Note that both D614G and N501Y are also present in the South African variant (B.1.351).


  Near-Complete Genome Sequences of Nine SARS-CoV-2 Strains Harboring the D614G Mutation in Malaysia.
 PMID: 34351228       2021       Microbiology resource announcements
Introduction: Of the nine strains sequenced, six were classified as the B.1.351 variant, which harbors the E484K and N501Y mutations commonly associated with increased transmission rate.


  Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants.
 PMID: 34351895       2021       PLoS computational biology
Abstract: We predict the same effect for several mutations on glycine residues (404, 416, 504, 252) as well as residues K417, D467 and N501, including the N501Y mutation recently observed within the B.1.1.7, 501.V2 and P1 strains.
Result: 501.V2 includes the mutations L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G, A701V.
Result: According to our calculations, the N501Y mutant shows DeltaSvib (open) = -1.60x10-2 J.K-1 and DeltaSvib (closed) = 2.37x10-1 J.K-1, with VDS = 2.53x10-1 J.K-1.


  Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.
 PMID: 34352039       2021       PLoS pathogens
Abstract: Using the already circulating mutation S494P, we found that it reduces antibody neutralization of convalescent and post-immunization sera, particularly when combined with E484K and with mutations able to increase binding to ACE2, such as N501Y.
Abstract: We confirmed that E484K evades antibody neutralization elicited by infection or vaccination, a capacity augmented when
Figure: (F, H) Paired analysis of neutralizing activity of convalescent sera (F) or post-vaccination sera (H) against WT vs S494P, S494P/N501Y, E484K/S494P or E484K/S494P/N501Y mutants.


  Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021.
 PMID: 34356077       2021       Genes
Result: The Spike_N501Y mutation was reported at 36.55% and 47.23% in SARS-CoV-2 genome sequences isolated from Africa and Europe, respectively.


  Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants.
 PMID: 34358019       2021       Pathogens (Basel, Switzerland)
Conclusion: (N501Y) mutation:to more than 80%.


  Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants.
 PMID: 34358195       2021       Vaccines
Result: The RBD variability data obtained for SARS-CoV-2 variants from Moscow patients (Figure 2, dashed lines) are generally consistent with the variability data for Russian sequences available in GISAID (Figure 2, solid lines and Figure S1) showing increasing prevalence of S477N, A522S, E484K, N501Y, T385I, S494P, N439K, K417N, T487K, N501T, and Y508H mutations.
Discussion: A significant percentage of the substitution variants that are becoming common is recorded: S477N + A522S (27.8%),



   Filtrator